Literature DB >> 35388184

An entorhinal-visual cortical circuit regulates depression-like behaviors.

Jian Lu1,2,3, Zhouzhou Zhang2,3, Xinxin Yin2,3, Yingjun Tang2,3, Runan Ji2,3, Han Chen2,3, Yu Guang4, Xue Gong1, Yong He1, Wei Zhou1, Haiyang Wang1, Ke Cheng1, Yue Wang1, Xiaowei Chen5, Peng Xie6, Zengcai V Guo7,8.   

Abstract

Major depressive disorder is viewed as a 'circuitopathy'. The hippocampal-entorhinal network plays a pivotal role in regulation of depression, and its main sensory output, the visual cortex, is a promising target for stimulation therapy of depression. However, whether the entorhinal-visual cortical pathway mediates depression and the potential mechanism remains unknown. Here we report a cortical circuit linking entorhinal cortex layer Va neurons to the medial portion of secondary visual cortex (Ent→V2M) that bidirectionally regulates depression-like behaviors in mice. Analyses of brain-wide projections of Ent Va neurons and two-color retrograde tracing indicated that Ent Va→V2M projection neurons represented a unique population of neurons in Ent Va. Immunostaining of c-Fos revealed that activity in Ent Va neurons was decreased in mice under chronic social defeat stress (CSDS). Both chemogenetic inactivation of Ent→V2M projection neurons and optogenetic inactivation of the projection terminals induced social deficiency, anxiety- and despair-related behaviors in healthy mice. Chemogenetic inactivation of Ent→V2M projection neurons also aggravated these depression-like behaviors in CSDS-resilient mice. Optogenetic activation of Ent→V2M projection terminals rapidly ameliorated depression-like phenotypes. Optical recording using fiber photometry indicated that elevated neural activity in Ent→V2M projection terminals promoted antidepressant-like behaviors. Thus, the Ent→V2M circuit plays a crucial role in regulation of depression-like behaviors, and can function as a potential target for treating major depressive disorder.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID: 35388184     DOI: 10.1038/s41380-022-01540-8

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  54 in total

1.  Medial reward and lateral non-reward orbitofrontal cortex circuits change in opposite directions in depression.

Authors:  Wei Cheng; Edmund T Rolls; Jiang Qiu; Wei Liu; Yanqing Tang; Chu-Chung Huang; XinFa Wang; Jie Zhang; Wei Lin; Lirong Zheng; JunCai Pu; Shih-Jen Tsai; Albert C Yang; Ching-Po Lin; Fei Wang; Peng Xie; Jianfeng Feng
Journal:  Brain       Date:  2016-10-14       Impact factor: 13.501

Review 2.  New targets for rTMS in depression: a review of convergent evidence.

Authors:  Jonathan Downar; Z Jeff Daskalakis
Journal:  Brain Stimul       Date:  2012-09-07       Impact factor: 8.955

3.  Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.

Authors:  Andre R Brunoni; Adriano H Moffa; Bernardo Sampaio-Junior; Lucas Borrione; Marina L Moreno; Raquel A Fernandes; Beatriz P Veronezi; Barbara S Nogueira; Luana V M Aparicio; Lais B Razza; Renan Chamorro; Luara C Tort; Renerio Fraguas; Paulo A Lotufo; Wagner F Gattaz; Felipe Fregni; Isabela M Benseñor
Journal:  N Engl J Med       Date:  2017-06-29       Impact factor: 91.245

4.  rTMS of the dorsomedial prefrontal cortex for major depression: safety, tolerability, effectiveness, and outcome predictors for 10 Hz versus intermittent theta-burst stimulation.

Authors:  Nathan Bakker; Saba Shahab; Peter Giacobbe; Daniel M Blumberger; Zafiris J Daskalakis; Sidney H Kennedy; Jonathan Downar
Journal:  Brain Stimul       Date:  2014-11-06       Impact factor: 8.955

5.  Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.

Authors:  John P O'Reardon; H Brent Solvason; Philip G Janicak; Shirlene Sampson; Keith E Isenberg; Ziad Nahas; William M McDonald; David Avery; Paul B Fitzgerald; Colleen Loo; Mark A Demitrack; Mark S George; Harold A Sackeim
Journal:  Biol Psychiatry       Date:  2007-06-14       Impact factor: 13.382

6.  Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.

Authors:  Daniel M Blumberger; Fidel Vila-Rodriguez; Kevin E Thorpe; Kfir Feffer; Yoshihiro Noda; Peter Giacobbe; Yuliya Knyahnytska; Sidney H Kennedy; Raymond W Lam; Zafiris J Daskalakis; Jonathan Downar
Journal:  Lancet       Date:  2018-04-26       Impact factor: 79.321

7.  Bilateral neuronavigated 20Hz theta burst TMS for treatment refractory depression: An open label study.

Authors:  William F Stubbeman; Bijan Zarrabi; Silvia Bastea; Victoria Ragland; Raya Khairkhah
Journal:  Brain Stimul       Date:  2018-04-21       Impact factor: 8.955

8.  Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-Immunoreactive neuropil.

Authors:  Tomasz Gos; Karoline Günther; Hendrik Bielau; Henrik Dobrowolny; Christian Mawrin; Kurt Trübner; Ralf Brisch; Johann Steiner; Hans-Gert Bernstein; Zbigniew Jankowski; Bernhard Bogerts
Journal:  J Affect Disord       Date:  2008-06-06       Impact factor: 4.839

9.  A systematic review and meta-analysis on the effects of transcranial direct current stimulation in depressive episodes.

Authors:  Lais B Razza; Priscila Palumbo; Adriano H Moffa; Andre F Carvalho; Marco Solmi; Colleen K Loo; Andre Russowsky Brunoni
Journal:  Depress Anxiety       Date:  2020-02-26       Impact factor: 6.505

Review 10.  Transcranial direct current stimulation: a roadmap for research, from mechanism of action to clinical implementation.

Authors:  Henry W Chase; Megan A Boudewyn; Cameron S Carter; Mary L Phillips
Journal:  Mol Psychiatry       Date:  2019-08-27       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.